Alnylam Pharmaceuticals Stock Price History
| ALNY Stock | USD 245.20 3.74 1.50% |
Below is the normalized historical share price chart for Alnylam Pharmaceuticals extending back to May 28, 2004. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Alnylam Pharmaceuticals stands at 245.20, as last reported on the 25th of February, with the highest price reaching 251.56 and the lowest price hitting 238.46 during the day.
If you're considering investing in Alnylam Stock, it is important to understand the factors that can impact its price. Alnylam Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.014, which signifies that the company had a -0.014 % return per unit of risk over the last 3 months. Alnylam Pharmaceuticals exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alnylam Pharmaceuticals' Risk Adjusted Performance of 0.0415, downside deviation of 1.86, and Mean Deviation of 1.53 to double-check the risk estimate we provide.
At this time, Alnylam Pharmaceuticals' Liabilities And Stockholders Equity is fairly stable compared to the past year. Capital Stock is likely to rise to about 1.3 M in 2025, whereas Total Stockholder Equity is likely to drop slightly above 63.7 M in 2025. . At this time, Alnylam Pharmaceuticals' Price Book Value Ratio is fairly stable compared to the past year. Price Earnings To Growth Ratio is likely to rise to 2.96 in 2025, whereas Price To Sales Ratio is likely to drop 12.79 in 2025. Alnylam Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of May 2004 | 200 Day MA 242.7663 | 50 Day MA 254.7692 | Beta 0.349 |
Alnylam |
Sharpe Ratio = -0.014
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALNY |
Estimated Market Risk
| 2.31 actual daily | 20 80% of assets are more volatile |
Expected Return
| -0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Alnylam Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Alnylam Pharmaceuticals by adding Alnylam Pharmaceuticals to a well-diversified portfolio.
Price Book 480.37 | Enterprise Value Ebitda 204.8549 | Price Sales 14.3343 | Shares Float 124.5 M | Wall Street Target Price 304.6067 |
Alnylam Pharmaceuticals Stock Price History Chart
There are several ways to analyze Alnylam Stock price data. The simplest method is using a basic Alnylam candlestick price chart, which shows Alnylam Pharmaceuticals price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 28, 2025 | 279.19 |
| Lowest Price | January 6, 2025 | 233.15 |
Alnylam Pharmaceuticals February 25, 2025 Stock Price Synopsis
Various analyses of Alnylam Pharmaceuticals' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Alnylam Stock. It can be used to describe the percentage change in the price of Alnylam Pharmaceuticals from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Alnylam Stock.| Alnylam Pharmaceuticals Accumulation Distribution | 62,432 | |
| Alnylam Pharmaceuticals Price Action Indicator | (1.68) | |
| Alnylam Pharmaceuticals Price Rate Of Daily Change | 0.98 | |
| Alnylam Pharmaceuticals Price Daily Balance Of Power | (0.29) |
Alnylam Pharmaceuticals February 25, 2025 Stock Price Analysis
Alnylam Stock Price History Data
The price series of Alnylam Pharmaceuticals for the period between Wed, Nov 27, 2024 and Tue, Feb 25, 2025 has a statistical range of 46.92 with a coefficient of variation of 5.55. The prices are distributed with arithmetic mean of 253.16. The median price for the last 90 days is 251.0.| Open | High | Low | Close | Volume | ||
| 02/25/2025 | 248.94 | 251.56 | 238.46 | 245.20 | 1,198,882 | |
| 02/24/2025 | 250.79 | 256.47 | 248.45 | 248.94 | 660,592 | |
| 02/21/2025 | 253.70 | 253.70 | 247.02 | 250.59 | 542,016 | |
| 02/20/2025 | 249.21 | 252.98 | 247.00 | 251.00 | 668,716 | |
| 02/19/2025 | 250.19 | 254.01 | 246.61 | 250.51 | 766,500 | |
| 02/18/2025 | 256.95 | 259.95 | 249.16 | 250.00 | 880,786 | |
| 02/14/2025 | 263.33 | 264.81 | 251.87 | 256.45 | 728,306 | |
| 02/13/2025 | 256.65 | 268.52 | 256.65 | 264.89 | 769,141 | |
| 02/12/2025 | 265.93 | 268.20 | 261.69 | 265.96 | 820,700 | |
| 02/11/2025 | 272.19 | 273.23 | 266.98 | 268.99 | 283,046 | |
| 02/10/2025 | 275.41 | 276.23 | 267.92 | 274.06 | 781,930 | |
| 02/07/2025 | 276.91 | 277.95 | 272.35 | 276.19 | 459,507 | |
| 02/06/2025 | 276.09 | 279.24 | 274.05 | 278.25 | 524,167 | |
| 02/05/2025 | 272.15 | 278.44 | 272.15 | 276.31 | 750,000 | |
| 02/04/2025 | 273.15 | 277.98 | 269.05 | 271.00 | 743,000 | |
| 02/03/2025 | 270.78 | 278.51 | 266.21 | 274.55 | 779,400 | |
| 01/31/2025 | 276.86 | 279.34 | 270.26 | 271.31 | 648,100 | |
| 01/30/2025 | 274.86 | 279.36 | 269.00 | 277.16 | 561,200 | |
| 01/29/2025 | 279.38 | 279.70 | 273.45 | 273.99 | 381,800 | |
| 01/28/2025 | 276.97 | 283.56 | 273.33 | 279.19 | 611,300 | |
| 01/27/2025 | 277.01 | 287.22 | 274.24 | 276.73 | 785,900 | |
| 01/24/2025 | 273.43 | 279.67 | 271.52 | 278.76 | 924,200 | |
| 01/23/2025 | 266.85 | 277.22 | 263.01 | 275.54 | 686,500 | |
| 01/22/2025 | 265.71 | 269.14 | 262.17 | 266.54 | 746,400 | |
| 01/21/2025 | 251.37 | 265.02 | 251.23 | 264.99 | 938,900 | |
| 01/17/2025 | 251.28 | 253.50 | 245.69 | 246.27 | 558,100 | |
| 01/16/2025 | 252.54 | 256.93 | 247.90 | 249.16 | 683,900 | |
| 01/15/2025 | 244.00 | 255.30 | 244.00 | 251.01 | 871,000 | |
| 01/14/2025 | 258.74 | 259.60 | 240.02 | 240.51 | 783,800 | |
| 01/13/2025 | 240.00 | 261.86 | 236.87 | 258.27 | 1,224,400 | |
| 01/10/2025 | 237.17 | 240.17 | 232.82 | 237.98 | 706,100 | |
| 01/08/2025 | 236.34 | 240.65 | 234.11 | 240.55 | 654,000 | |
| 01/07/2025 | 234.00 | 239.23 | 232.98 | 235.95 | 629,000 | |
| 01/06/2025 | 234.09 | 237.49 | 231.00 | 233.15 | 561,500 | |
| 01/03/2025 | 232.59 | 235.53 | 232.35 | 234.28 | 411,200 | |
| 01/02/2025 | 237.92 | 239.99 | 232.25 | 233.62 | 392,700 | |
| 12/31/2024 | 237.26 | 238.44 | 235.16 | 235.31 | 370,100 | |
| 12/30/2024 | 235.73 | 236.95 | 233.00 | 236.01 | 382,300 | |
| 12/27/2024 | 241.81 | 243.61 | 237.15 | 237.97 | 342,900 | |
| 12/26/2024 | 241.78 | 244.82 | 240.43 | 242.50 | 358,600 | |
| 12/24/2024 | 241.70 | 243.90 | 236.70 | 243.25 | 253,100 | |
| 12/23/2024 | 244.63 | 244.64 | 237.12 | 242.26 | 718,100 | |
| 12/20/2024 | 239.45 | 247.21 | 235.93 | 245.44 | 1,663,600 | |
| 12/19/2024 | 238.11 | 242.87 | 233.41 | 238.87 | 975,100 | |
| 12/18/2024 | 245.67 | 247.05 | 237.25 | 237.92 | 543,100 | |
| 12/17/2024 | 242.70 | 249.58 | 240.42 | 246.58 | 634,400 | |
| 12/16/2024 | 246.44 | 247.93 | 242.13 | 243.99 | 598,900 | |
| 12/13/2024 | 246.01 | 249.51 | 241.89 | 245.44 | 591,900 | |
| 12/12/2024 | 255.02 | 255.47 | 244.84 | 245.26 | 751,000 | |
| 12/11/2024 | 254.50 | 255.92 | 250.21 | 254.15 | 453,500 | |
| 12/10/2024 | 257.72 | 257.99 | 250.33 | 253.91 | 463,300 | |
| 12/09/2024 | 255.39 | 258.12 | 252.20 | 255.89 | 611,000 | |
| 12/06/2024 | 251.60 | 257.81 | 250.65 | 256.26 | 575,500 | |
| 12/05/2024 | 252.99 | 255.29 | 250.21 | 251.81 | 460,400 | |
| 12/04/2024 | 250.39 | 256.68 | 250.35 | 254.72 | 422,400 | |
| 12/03/2024 | 250.59 | 253.21 | 247.38 | 251.84 | 404,200 | |
| 12/02/2024 | 252.37 | 255.29 | 252.00 | 253.01 | 510,700 | |
| 11/29/2024 | 250.59 | 254.18 | 250.01 | 253.07 | 325,600 | |
| 11/27/2024 | 253.98 | 256.02 | 250.27 | 253.74 | 718,100 | |
| 11/26/2024 | 249.37 | 253.74 | 247.76 | 253.35 | 985,800 | |
| 11/25/2024 | 247.36 | 255.46 | 247.36 | 250.98 | 1,213,300 |
About Alnylam Pharmaceuticals Stock history
Alnylam Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Alnylam is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Alnylam Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Alnylam Pharmaceuticals stock prices may prove useful in developing a viable investing in Alnylam Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 128.6 M | 73.5 M | |
| Net Loss | -1 B | -967.1 M |
Alnylam Pharmaceuticals Quarterly Net Working Capital |
|
Alnylam Pharmaceuticals Stock Technical Analysis
Alnylam Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Alnylam Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Alnylam Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Alnylam Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Alnylam to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0415 | |||
| Jensen Alpha | 0.1049 | |||
| Total Risk Alpha | 0.1156 | |||
| Sortino Ratio | 0.0566 | |||
| Treynor Ratio | 0.1037 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Alnylam Stock Analysis
When running Alnylam Pharmaceuticals' price analysis, check to measure Alnylam Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alnylam Pharmaceuticals is operating at the current time. Most of Alnylam Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alnylam Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alnylam Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alnylam Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.